Table 1.
Variable | Number | % |
---|---|---|
Total | 58,115 | — |
Age (years) | ||
18-34 | 18,358 | 31.6 |
35-49 | 19,290 | 33.2 |
50-70 | 17,457 | 30.0 |
≥70 | 3,010 | 5.2 |
Sex | ||
Male | 38,957 | 67.0 |
Female | 19,158 | 33.0 |
Marital status | ||
Married or cohabitation | 40,224 | 69.2 |
Other | 17,891 | 30.8 |
Route of HIV transmission | ||
Heterosexual intercourse | 49,608 | 85.4 |
Intravenous drug use | 5,954 | 10.2 |
Homosexual intercourse | 925 | 1.6 |
Other | 1,628 | 2.8 |
CD4 cell count (cells/μL) before ART | ||
<200 | 34,774 | 59.8 |
200-350 | 16,252 | 28.0 |
350-500 | 4,550 | 7.8 |
≥500 | 1,648 | 2.8 |
Missing | 891 | 1.5 |
Initial ART regimen | ||
The first-line ART containing D4T | 14,244 | 24.5 |
The first-line ART containing AZT | 23,059 | 39.7 |
The first-line ART containing TDF | 13,965 | 24.0 |
The first-line ART containing LPV/r | 4,510 | 7.8 |
Other | 2,337 | 4.0 |
Level of ART site | ||
Provincial | 10,920 | 18.8 |
Prefecture | 22,525 | 38.8 |
County | 24,670 | 42.4 |
Year of ART initiation | ||
2003-2008 | 7,741 | 13.3 |
2009-2011 | 17,800 | 30.6 |
2012-2015 | 32,574 | 56.1 |
ART: antiretroviral therapy; D4T: stavudine; AZT: azidothymidine; TDF: tenofovir; LPV/r: ritonavir-boosted lopinavir; HR: hazard ratio; AHR: adjusted hazard ratio.